EMPLOYMENT AGREEMENTEmployment Agreement • March 11th, 2005 • Dor Biopharma Inc • Pharmaceutical preparations • Florida
Contract Type FiledMarch 11th, 2005 Company Industry JurisdictionThis Agreement (the “Agreement”), dated as of December 9, 2004 (the “Effective Date”) by and between DOR BioPharma, Inc., a Delaware corporation having a place of business at 1691 Michigan Avenue, Suite 435, Miami, FL 33139 (the “Corporation”), and Evan Myrianthopoulos, an individual (the “Employee”).
EMPLOYMENT AGREEMENTEmployment Agreement • March 11th, 2005 • Dor Biopharma Inc • Pharmaceutical preparations • Florida
Contract Type FiledMarch 11th, 2005 Company Industry JurisdictionThis Agreement (the “Agreement”), dated September 1, 2004 effective as of July 1, 2004(the “Effective Date”) by and between DOR Biopharma, Inc., a Delaware corporation having a place of business at Lincoln Building, 1691 Michigan Avenue, Suite 435, Miami Beach, FL33139 (the ‘Corporation), and Gregory J. Davenport Ph.D. an individual residing at 2185Windermere Court, Frederick, MD 21702 (the “Employee”).
AMENDMENT NO. 1 TO THE SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 11th, 2005 • Dor Biopharma Inc • Pharmaceutical preparations • New York
Contract Type FiledMarch 11th, 2005 Company Industry JurisdictionThis Amendment No. 1 (“Amendment”) to the Securities Purchase Agreement (the “Purchase Agreement”) dated as of February 1, 2005, by and among DOR BioPharma, Inc., a Delaware corporation (the “Company”), and the investors named therein (the “Investors”), is made and entered into as of February 17, 2005. Capitalized terms not defined in this Amendment shall have the meanings ascribed to them in the Purchase Agreement.
EMPLOYMENT AGREEMENTEmployment Agreement • March 11th, 2005 • Dor Biopharma Inc • Pharmaceutical preparations • Florida
Contract Type FiledMarch 11th, 2005 Company Industry JurisdictionThis Agreement (the “Agreement”), dated as of February 18, 2005 (the “Effective Date”) by and between DOR BioPharma, Inc., a Delaware corporation having a place of business at 1691 Michigan Avenue, Suite 435, Miami, FL 33139 (the “Corporation”), and James Clavijo, an individual (the “Employee”).